Table 4.
Variables | Mild–moderate AAC versus no AAC |
Severe AAC versus no AAC |
||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Supplemental zinc intake (per 1 mg/day; n = 1870) | ||||
Unadjusted | 1.01 (0.99–1.03) | 0.20 | 1.03 (1.01–1.04) | 0.002 |
Model 1 | 1.00 (0.98–1.01) | 0.86 | 1.00 (0.98–1.02) | 0.95 |
Model 2 | 1.00 (0.98–1.01) | 0.91 | 1.00 (0.97–1.02) | 0.74 |
Total zinc intake (per 1 mg/day; n = 1870) | ||||
Unadjusted | 1.01 (0.99–1.02) | 0.36 | 1.02 (1.00–1.03) | 0.01 |
Model 1 | 1.00 (0.98–1.01) | 0.53 | 0.99 (0.97–1.01) | 0.42 |
Model 2 | 1.00 (0.98–1.01) | 0.55 | 0.99 (0.97–1.01) | 0.42 |
Serum zinc level (per 1 μg/dL; n = 800) | ||||
Unadjusted | 1.01 (1.00–1.03) | 0.07 | 1.00 (0.97–1.04) | 0.76 |
Model 1 | 1.02 (1.00–1.03) | 0.06 | 1.01 (0.98–1.04) | 0.50 |
Model 2 | 1.01 (1.00–1.03) | 0.11 | 1.01 (0.98–1.03) | 0.71 |
Model 1: Adjusted for age, sex and race/ethnicity.
Model 2: Adjusted for variables in Model 1 plus caloric intake, diabetes, hypertension, smoking history, eGFR, albuminuria, albumin, serum phosphorus, proton pump inhibitor and diuretic use.